Wave Life Sciences, Inc. WVE

US Pharmaceuticals

$3.52 ▲ +1.15% (+$0.04)

⚡ High Volume

Open $3.43

Prev Close $3.48

Day Range $3.37 – $3.57

52W Range $3.04 – $21.73

Market Cap $708.05M

Beta -1.38

EPS (TTM) $-1.07

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-11-11
Shares Out.	197,230,000
Website	wavelifesciences.com ↗
Phone	16179492900
Employees	317
Revenue	$13.2M
Gross Profit	$13.2M
Net Income	-$61.9M
Free Cash Flow	-$208.4M
Total Assets	$507.9M
Total Liabilities	$106.0M
Equity	$401.9M

About Wave Life Sciences, Inc.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Wave Life Sciences, Inc. is a publicly traded company under the ticker symbol WVE on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.